These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11338801)

  • 21. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
    Smrkolj S; Rakar S; Mozina A; Erzen M
    Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome analysis of cervical adenosquamous carcinoma compared with adenocarcinoma.
    Chen JL; Cheng JC; Kuo SH; Chen CA; Lin MC; Huang CY
    Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1158-66. PubMed ID: 22497449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cancer incidence in the south of Thailand 1988-1989.
    Chichareon SB
    J Med Assoc Thai; 1993 Mar; 76(3):146-52. PubMed ID: 8228710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends of histopathology of cervical cancer among women in Durban, South Africa.
    Moodley M; Moodley K
    Eur J Gynaecol Oncol; 2009; 30(2):145-50. PubMed ID: 19480242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors of primary adenocarcinoma of the uterine cervix.
    Chen RJ; Chang DY; Yen ML; Lee EF; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1998 May; 69(2):157-64. PubMed ID: 9600824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): a pooled analysis.
    Hou J; Goldberg GL; Qualls CR; Kuo DY; Forman A; Smith HO
    Gynecol Oncol; 2011 Apr; 121(1):135-42. PubMed ID: 21193227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.
    Smith HO; Tiffany MF; Qualls CR; Key CR
    Gynecol Oncol; 2000 Aug; 78(2):97-105. PubMed ID: 10926787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased incidence of adenocarcinoma of uterine cervix.
    Davis JR; Moon LB
    Obstet Gynecol; 1975 Jan; 45(1):79-83. PubMed ID: 46115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

  • 31. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the histopathological pattern of carcinoma of the cervix in Ilorin, Nigeria.
    Adeniji KA
    Niger J Med; 2001; 10(4):165-8. PubMed ID: 11805997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence trends of adenocarcinoma of the cervix in 13 European countries.
    Bray F; Carstensen B; Møller H; Zappa M; Zakelj MP; Lawrence G; Hakama M; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2191-9. PubMed ID: 16172231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of peritoneal cytology in patients with carcinoma of the uterine cervix.
    Takeshima N; Katase K; Hirai Y; Yamawaki T; Yamauchi K; Hasumi K
    Gynecol Oncol; 1997 Jan; 64(1):136-40. PubMed ID: 8995562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenocarcinoma in situ of the cervix: sensitivity of detection by cervical smear: will cytologic screening for adenocarcinoma in situ reduce incidence rates for adenocarcinoma.
    Smith HO; Padilla LA
    Cancer; 2002 Dec; 96(6):319-22. PubMed ID: 12478677
    [No Abstract]   [Full Text] [Related]  

  • 36. Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas.
    Ogura K; Ishi K; Matsumoto T; Kina K; Nojima M; Suda K
    Pathol Int; 2006 Jun; 56(6):301-8. PubMed ID: 16704493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.
    Sherman ME; Wang SS; Carreon J; Devesa SS
    Cancer; 2005 Mar; 103(6):1258-64. PubMed ID: 15693030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Socioeconomic differences in incidence of cervical cancer in Finland by cell type.
    Pukkala E; Malila N; Hakama M
    Acta Oncol; 2010; 49(2):180-4. PubMed ID: 20001504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cervical cancer before 35 years of age: epidemiological and prognostic aspects. Retrospective study of 46 cases of cervical cancer before 35 years of age in a series of 449 cases in stages IA2 and IV].
    Saint-Paul MT; Brémond A; Rochet Y
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):737-42. PubMed ID: 8308199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A population-based survey of the management of women with cancer of the cervix.
    Clarke F; Dey P; Collins S
    Br J Cancer; 1999 Aug; 80(12):1958-61. PubMed ID: 10471045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.